BioMarin Pharmaceutical, Inc. (BMRN)
58.95
-1.40
(-2.32%)
USD |
NASDAQ |
Jan 09, 16:00
58.98
+0.03
(+0.05%)
After-Hours: 20:00
BioMarin Pharmaceutical Accounts Payable (Quarterly): 389.67M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 19.10M |
| Gilead Sciences, Inc. | 808.00M |
| Merck & Co., Inc. | 4.147B |
| AbbVie, Inc. | 33.36B |
| Bristol Myers Squibb Co. | 4.288B |